GB1425706A - Piperidine derivatives - Google Patents

Piperidine derivatives

Info

Publication number
GB1425706A
GB1425706A GB3063672A GB3063672A GB1425706A GB 1425706 A GB1425706 A GB 1425706A GB 3063672 A GB3063672 A GB 3063672A GB 3063672 A GB3063672 A GB 3063672A GB 1425706 A GB1425706 A GB 1425706A
Authority
GB
United Kingdom
Prior art keywords
group
formula
compound
alkyl
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3063672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Priority to GB3063672A priority Critical patent/GB1425706A/en
Priority to US05/569,242 priority patent/US4024147A/en
Publication of GB1425706A publication Critical patent/GB1425706A/en
Priority to US05/771,591 priority patent/US4061758A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

1425706 Piperidine derivatives JOHN WYETH & BRO Ltd 28 June 1973 [30 June 1972] 30636/72 Heading C2C The invention comprises piperidine derivatives of the Formula (I): or an acid addition salt thereof, in which A is a C 2 -C 6 alkyl group optionally substituted by a C 1 -C 6 alkoxy group, hydroxy, amino optionally substituted by one or two C 1 -C 6 alkyl groups, halogen, a cyano group, an optionally substituted carbamoyl group of formula (in which X and Y are hydrogen or lower alkyl), a group of formula -COT (in which T is C 1 -C 6 alkyl), or an oxime, an optionally substituted hydrazone, guanidone, aminoguanidone or semicarbazone derivative of the group -COT; or A represents a group of formula -COOB in which B is an optionally substituted C 1 -C 6 alkyl group; and R represents a C 5 -C 7 oycloalkyl group or an aryl or heteroaryl group; with the proviso that when A is an unsubstituted C 2 -C 6 alkyl group and the group RCONH- is in the 4-position of the piperidine ring then R is a phenyl group substituted by one or more substituents at least one of which is in the 2- or 3- position. They may be prepared by (a) reacting a compound of Formula II: with a compound of formula RCOOH or a functional derivative thereof; (b) reacting a compound of Formula III: with an alcohol of formula BOH; (c) reacting a compound having the Formula IV: or an acid addition salt thereof with an alkylating agent AZ where Z is a leaving group or atom ; (d) reacting a compound having an ion of Formula V: or (e) reacting a compound of the Formula VI: in which A<SP>1</SP> is a C 2 -C 6 alkyl group monosubstituted by a carboxyl group or a derivative thereof is amidated to produce the compound where A is an alkyl group monosubstituted by a substituted or unsubstituted carbamoyl group where X and Y are hydrogen or C 1 -C 6 alkyl, and, if desired, converting the free base into an acid addition salt or vice versa. The products may be used as the active ingredients in pharmaceutical compositions.
GB3063672A 1972-06-30 1972-06-30 Piperidine derivatives Expired GB1425706A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB3063672A GB1425706A (en) 1972-06-30 1972-06-30 Piperidine derivatives
US05/569,242 US4024147A (en) 1972-06-30 1975-04-18 Heterocyclic compounds
US05/771,591 US4061758A (en) 1972-06-30 1977-02-24 Treating hypertension and central nervous system abnormalities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3063672A GB1425706A (en) 1972-06-30 1972-06-30 Piperidine derivatives

Publications (1)

Publication Number Publication Date
GB1425706A true GB1425706A (en) 1976-02-18

Family

ID=10310735

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3063672A Expired GB1425706A (en) 1972-06-30 1972-06-30 Piperidine derivatives

Country Status (1)

Country Link
GB (1) GB1425706A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230718A1 (en) * 1985-11-02 1987-08-05 Beecham Group Plc Substituted benzamides and benzoates
WO2001093849A2 (en) * 2000-06-07 2001-12-13 Aryx Therapeutics Treatment of gastroesophageal reflux disease using piperidine derivatives
US7176218B2 (en) 2004-01-07 2007-02-13 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US7326787B2 (en) 2005-08-31 2008-02-05 Aryx Therapeutics, Inc. Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230718A1 (en) * 1985-11-02 1987-08-05 Beecham Group Plc Substituted benzamides and benzoates
US4853394A (en) * 1985-11-02 1989-08-01 Beecham Group P.L.C. N-('-B-hydroxyethylpiperid-4-yl esters and amides
WO2001093849A2 (en) * 2000-06-07 2001-12-13 Aryx Therapeutics Treatment of gastroesophageal reflux disease using piperidine derivatives
WO2001093849A3 (en) * 2000-06-07 2003-01-30 Aryx Therapeutics Treatment of gastroesophageal reflux disease using piperidine derivatives
AU2001275326B2 (en) * 2000-06-07 2006-02-02 Aryx Therapeutics Treatment of gastroesophageal reflux disease using piperidine derivatives
AU2001275326C1 (en) * 2000-06-07 2006-09-21 Aryx Therapeutics Treatment of gastroesophageal reflux disease using piperidine derivatives
US7176218B2 (en) 2004-01-07 2007-02-13 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US7282509B2 (en) 2004-01-07 2007-10-16 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US7326787B2 (en) 2005-08-31 2008-02-05 Aryx Therapeutics, Inc. Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
US7629466B2 (en) 2005-08-31 2009-12-08 Aryx Therapeutics, Inc. Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders

Similar Documents

Publication Publication Date Title
NO930201L (en) SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS WITH SELECTIVE LEUKOTRIEN-B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE
GB1310329A (en) Chewing gum compositions and candy products containing a flavour preservative
GB1209946A (en) Homopyrimidazole derivatives
GB1424571A (en) 3,4-dihydrocarbostyril derivatives their preparation and pharmaceutical compositions thereof
IE41528L (en) Furfuryl-benzomorphane derivatives.
SE7807810L (en) 3-METHYLENIC LAMIC ACID DERIVATIVE
ES460040A1 (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
GB1351501A (en) Adenosine derivatives and the production thereof
GB1425706A (en) Piperidine derivatives
GB1373212A (en) Pyrazole compounds
GB1469245A (en) Substituted p-phenylenediamines
GB1381361A (en) Salts of chlorhexidine processes for their preparation and compo sitions incorporating them
GB1415591A (en) Benzocycloheptathiophene derivatives
GB1432816A (en) Pharmaceutical antimycotic compositions medicaments and method
GB1289240A (en)
GB1129158A (en) Coronary dilating compositions
GB1247714A (en) Phenylglycine derivatives
GB1304599A (en)
GB1464259A (en) Imidazo-thiazole and -thiadiazole sulphonamides and their use as therapeutic agents
GB1325770A (en) Pyrimidopyridazine derivatives
GB1207930A (en) Azacycloaliphatic compounds, process for their manufacture and compositions containing them
GB1412932A (en) Pharmaceutically active leurosine derivatives and preparation thereof
GB1505525A (en) Pyridopyrimidines
IE34141B1 (en) Sweetening compositions and method
GB1457092A (en) Acyloxy-phenylethanolamines

Legal Events

Date Code Title Description
PS Patent sealed
746 Register noted 'licences of right' (sect. 46/1977)
PCNP Patent ceased through non-payment of renewal fee